GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » Institutional Ownership

Sci Pharmtech (TPE:4119) Institutional Ownership : 0.44% (As of Sep. 25, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Sci Pharmtech Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sci Pharmtech's institutional ownership is 0.44%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sci Pharmtech's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sci Pharmtech's Float Percentage Of Total Shares Outstanding is 0.00%.


Sci Pharmtech Institutional Ownership Historical Data

The historical data trend for Sci Pharmtech's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sci Pharmtech Institutional Ownership Chart

Sci Pharmtech Historical Data

The historical data trend for Sci Pharmtech can be seen below:

2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31
Institutional Ownership 0.28 0.25 0.31 0.31 0.34 0.43 0.44 0.44 0.44 0.44

Sci Pharmtech Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Sci Pharmtech Business Description

Traded in Other Exchanges
N/A
Address
No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Sci Pharmtech Inc is engaged in research and development, manufacture and sale of active pharmaceutical ingredients, intermediates, specialty chemicals. Geographically, the primary markets of company are Italy, Germany, Japan, Taiwan, United states, China, Switzerland, Spain and others.

Sci Pharmtech Headlines

No Headlines